Zoledronate Following Denosumab Discontinuation: Partial Reassurance but No Confidence

J Bone Miner Res. 2020 Jul;35(7):1205-1206. doi: 10.1002/jbmr.4022. Epub 2020 Apr 21.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Bone Density
  • Denosumab*
  • Diphosphonates / adverse effects
  • Female
  • Humans
  • Postmenopause*
  • Zoledronic Acid

Substances

  • Diphosphonates
  • Denosumab
  • Zoledronic Acid